# Hervé Tilly

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/herve-tilly/

## Facts

| Field | Value |
| --- | --- |
| Citations | 45,405 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 104 |
| i10-index | 368 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5003078312 |
| ORCID iD | https://orcid.org/0000-0001-7022-5246 |
| Works | 807 |

## Researcher papers

- [Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).](https://scholariq.org/papers/prognostic-significance-of-t-cell-phenotype-in-aggressive-non-hodgkin-s/)
- [Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma](https://scholariq.org/papers/rituximab-plus-lenalidomide-in-advanced-untreated-follicular-lymphoma/)
- [Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study](https://scholariq.org/papers/safety-and-activity-of-the-anti-cd79b-antibody-drug-conjugate-polatuzumab/)
- [Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies](https://scholariq.org/papers/prognostic-value-of-pet-ct-after-first-line-therapy-in-patients-with-follicular/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.